Search Results - "Albalawy, Rakan"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Perivascular Adipose Tissue and Perivascular Adipose Tissue-Derived Extracellular Vesicles: New Insights in Vascular Disease by Sigdel, Smara, Udoh, Gideon, Albalawy, Rakan, Wang, Jinju

    Published in Cells (Basel, Switzerland) (06-08-2024)
    “…Perivascular adipose tissue (PVAT) is a special deposit of fat tissue surrounding the vasculature. Previous studies suggest that PVAT modulates the vasculature…”
    Get full text
    Journal Article
  2. 2

    Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors by El-Behaedi, Salma, Landsman, Rebekah, Rudloff, Michael, Kolyvas, Emily, Albalawy, Rakan, Zhang, Xianyu, Bera, Tapan, Collins, Keith, Kozlov, Serguei, Alewine, Christine

    Published in Toxins (31-10-2018)
    “…LMB-100 is a mesothelin-targeted recombinant immunotoxin (iTox) that carries a modified exotoxin A (PE) payload. PE kills cells by inhibiting synthesis of new…”
    Get full text
    Journal Article
  3. 3

    Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases by Avula, Leela Rani, Rudloff, Michael, El-Behaedi, Salma, Arons, Danielle, Albalawy, Rakan, Chen, Xiongfong, Zhang, Xianyu, Alewine, Christine

    Published in Molecular cancer research (01-02-2020)
    “…Over 90% of pancreatic ductal adenocarcinomas (PDAC) express mesothelin (MSLN). Overexpression or knockdown of MSLN has been implicated in PDAC aggressiveness…”
    Get full text
    Journal Article
  4. 4

    Dysphagia with Blood Disorder? an Unusual Presentation for Paroxysmal Nocturnal Hemoglobinuria by Sheikh, Taha, Albalawy, Rakan, Shuja, Hina, Kahlon, Navkirat M, Hamouda, Danae M

    Published in Blood (05-11-2020)
    “…Paroxysmal Nocturnal Hemoglobinuria (PNH) is an acquired hemolytic disorder of the multipotent myeloid stem cells, due to underexpression of surface complement…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Abstract 3964: Mesothelin targeting immunotoxin LMB-100 alters the profile of tumor-secreted proteins by El-Behaedi, Salma, Landsman, Rebekah, Rudloff, Michael, Kolyvas, Emily, AlBalawy, Rakan, Alewine, Christine

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Recombinant immunotoxins are antibody-based therapies that carry a bacterial toxin payload. LMB-100 is a next generation immunotoxin currently being tested in…”
    Get full text
    Journal Article
  7. 7

    Abstract 4342: Loss of MSLN impairs pancreatic cancer growth in the peritoneal cavity by Rudloff, Michael W., Arons, Danielle, El-Behaedi, Salma, Albalawy, Rakan, Alewine, Christine

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Mesothelin (MSLN) is a cell surface glycoprotein that is expressed in at least 85% of pancreatic adenocarcinoma but not on cells of the healthy pancreas nor in…”
    Get full text
    Journal Article